Valeo Financial Advisors, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,728
-85.0%
14,825
-2.3%
0.00%
-100.0%
Q2 2023$18,132
+72.9%
15,1730.0%0.00%0.0%
Q1 2023$10,488
+1.8%
15,1730.0%0.00%0.0%
Q4 2022$10,302
-31.3%
15,173
+2.3%
0.00%0.0%
Q3 2022$15,000
+50.0%
14,8250.0%0.00%0.0%
Q2 2022$10,000
-33.3%
14,825
+394.2%
0.00%0.0%
Q1 2021$15,0003,0000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders